Organisation › Details

ImmunoGen Inc. (Nasdaq: IMGN)

ImmunoGen is a clinical-stage biotechnology company that develops targeted cancer therapeutics using its proprietary ADC technology. ImmunoGen's lead product candidate, mirvetuximab soravtansine, is in a Phase 3 trial for FRa-positive platinum-resistant ovarian cancer, and is in Phase 1b/2 testing in combination regimens for earlier-stage disease. ImmunoGen's ADC technology is used in Roche's marketed product, Kadcyla®, in three other clinical-stage ImmunoGen product candidates, and in programs in development by partners Amgen, Bayer, Biotest, CytomX, Lilly, Novartis, Sanofi and Takeda. *


Period Start 1991-01-01 existent
Product Industry MAb
Person Person Enyedy, Mark J. (ImmunoGen 201705 CEO before Genzyme 200803 President Genzyme Oncology)
  Street 830 Winter Street
  City 02451-1477 Waltham, MA
  Tel +1-781-895-0600
    Address record changed: 2018-07-24
Basic data Employees n. a.
  Currency USD
  Annual sales 38,212,000 (revenues, total (2006/07) 2007-06-30)
  Profit -18,987,000 (2007-06-30)
  Cash 41,200,000 (2008-03-31)
    * Document for �About Section�: Debiopharm International SA. (5/24/17). "Press Release: Debiopharm International SA Enters the Field of Antibody-Drug Conjugates through Acquisition of Phase II Asset from ImmunoGen". Lausanne.
Record changed: 2018-10-31


[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for ImmunoGen Inc. (Nasdaq: IMGN)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [iito] – Putting Information into Context 600x60px

» top